Skip to main content

ANAVEX LIFE SCIENCES CORP

For the period ended Jun 30, 2024. Filed Aug 6, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 6, 2024

AVXL$1.22+6.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

ITEM 6. EXHIBITS

Exhibit NumberDescription
(3)Articles of Incorporation and Bylaws
3.1Articles of Incorporation (incorporated by reference to Exhibit 3.1 to our Annual Report on Form 10-K for the year ended September 30, 2021, filed on November 24, 2021)
3.2Bylaws (incorporated by reference to our Current Report on Form 8-K filed on April 14, 2023)
(31)Rule 13a-14(a)/15(d)-14(a)Certifications
31.1*Certification of Christopher Missling, PhD.
31.2*Certification of Sandra Boenisch
(32)Section 1350 Certifications
32.1**Certification of Christopher Missling, PhD and Sandra Boenisch.
(101)XBRL
101.INS*XBRL INSTANCE DOCUMENT
101.SCH*XBRL TAXONOMY EXTENSION SCHEMA
101.CAL*XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
101.DEF*XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
101.LAB*XBRL TAXONOMY EXTENSION LABEL LINKBASE
101.PRE*XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
  • Filed herewith.

** Furnished herewith.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.